A Novel Non-Invasive Method of Estimating Pulmonary Vascular Resistance in Patients With Pulmonary Arterial Hypertension

Background The assessment of pulmonary vascular resistance (PVR) plays an important role in the diagnosis and management of pulmonary arterial hypertension (PAH). The main objective of this study was to determine whether the noninvasive index of systolic pulmonary arterial pressure (SPAP) to heart r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Society of Echocardiography 2009-05, Vol.22 (5), p.523-529
Hauptverfasser: Haddad, François, MD, Zamanian, Roham, MD, Beraud, Anne-Sophie, MD, Schnittger, Ingela, MD, Feinstein, Jeffrey, MD, MPH, Peterson, Tyler, MD, Yang, Phil, MD, Doyle, Ramona, MD, Rosenthal, David, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The assessment of pulmonary vascular resistance (PVR) plays an important role in the diagnosis and management of pulmonary arterial hypertension (PAH). The main objective of this study was to determine whether the noninvasive index of systolic pulmonary arterial pressure (SPAP) to heart rate (HR) times the right ventricular outflow tract time-velocity integral (TVIRVOT ) (SPAP/[HR × TVIRVOT ]) provides clinically useful estimations of PVR in PAH. Methods Doppler echocardiography and right-heart catheterization were performed in 51 consecutive patients with established PAH. The ratio of SPAP/(HR × TVIRVOT ) was then correlated with invasive indexed PVR (PVRI) using regression and Bland-Altman analysis. Using receiver operating characteristic curve analysis, a cutoff value for the Doppler equation was generated to identify patients with PVRI ≥ 15 Wood units (WU)/m2. Results The mean pulmonary arterial pressure was 52 ± 15 mm Hg, the mean cardiac index was 2.2 ± 0.6 L/min/m2 , and the mean PVRI was 20.5 ± 9.6 WU/m2 . The ratio of SPAP/(HR × TVIRVOT ) correlated very well with invasive PVRI measurements ( r = 0.860; 95% confidence interval, 0.759-0.920). A cutoff value of 0.076 provided well-balanced sensitivity (86%) and specificity (82%) to determine PVRI > 15 WU/m2 . A cutoff value of 0.057 increased sensitivity to 97% and decreased specificity to 65%. Conclusion The novel index of SPAP/(HR × TVIRVOT ) provides useful estimations of PVRI in patients with PAH.
ISSN:0894-7317
1097-6795
DOI:10.1016/j.echo.2009.01.021